Chinese Firm Sinopharm Reports Promising Results for COVID-19 Vaccine Trials
The anti-Covid vaccine from the Chinese pharmaceutical group Sinopharm, chosen by Morocco, is about to be completed thanks to the results of clinical trials.
In a press release, the pharmaceutical group indicated on Wednesday, November 11 that the data obtained from the large-scale clinical trials were "better than expected".
According to Reuters, the 3rd phase of clinical trials has been launched for the two vaccine candidates by China National Biotec Group (CNBG), which is a Sinopharm unit. These trials have been conducted in the United Arab Emirates, Bahrain and Egypt on more than 50,000 volunteers from these countries.
Pending the completion of the trials, the group should provide more details on the data from the trials of one of the two group’s vaccines.
Related Articles
-
Moroccan Official Reassigned After Assault; Attacker Sentenced to Prison
19 April 2025
-
Ryanair’s Abrupt Cancellation of Malaga-Nador Route Sparks Outrage Among Moroccan Expats
19 April 2025
-
Moroccan Court Orders Repayment as Swiss Entrepreneur’s Textile Firm Faces Bankruptcy
19 April 2025
-
Moroccan Officials Under Investigation for Undeclared Foreign Assets and Bitcoin Trafficking
19 April 2025
-
Moroccan Real Estate Developers Accused of Tax Evasion Scheme in Jorf El Melha
19 April 2025